By Brian Mahoney ( September 26, 2013, 4:51 PM EDT) -- Pharmaceutical companies may still be filing so-called citizen petitions to delay approval of generic versions of their drugs, and the delays caused by those petitions are keeping the U.S. Food and Drug Administration from performing other regulatory work, the agency said in a report to Congress released on Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.